Dermapharm Holding SE buy thorstenm
Start price
12.01.23
/
80%
€39.44
Target price
12.01.26
€60.00
Performance (%)
-2.76%
End price
12.01.26
€38.35
Summary
This prediction ended on 12.01.26 with a price of €38.35. With a performance of -2.76%, the BUY prediction by thorstenm finished with a loss. thorstenm has 80% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -2.225% | -2.225% | 20.763% | -7.938% |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % | 65,58 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % | 90,18 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % | 84,99 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % | 70,76 % |
Comments by thorstenm for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE
Die von thorstenm gewählte maximale Laufzeit wurde überschritten